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Pyrimidine metabolism in Trichomonas vagbtalti was investigated using washed cell suspensions of the or- 
ganism with radiolabelled pyrimidine ring precursors and preformed pyriruidines. The precursors [l*c]oro- 
tate, [‘~Jbi~r~nate and [l4cfaspartate were not in~~~~ into the pyrimidine bases of tricbomonal 
nucleic acids, indicating that the protozoan is unable to synthesise the pyrimidine ring and is dependent 
on the salvage of exogenous pyrimidiues. [W)uracil, [Wluridine, [Wjcytidine, deoxy[3Hlcytidine and 
[jH&hymidine were all efficiently salvaged, and interconversion between cytosine and uracil nucleotides was 
detected. ~~idyla~ syntltase activity was not detected, suggesting that T. vagzkalis is dependent upon 
an exogenous supply of thymidine for TMP synthesis. 
Pyrimidine synthesb Pyritnidine salvage 
1. INTRODUCTION 
Whilst the purine metabolism of several general 
of parasitic protozoa has been intensively studied, 
frequently with a view to establishing possible 
chemotherapeutic targets [l-4], our knowledge of 
pyrimidine metabolism in this group of organisms 
is less well advanced. Trypanosoma, Leishmania, 
Toxoplasma and Pl~modi~m species are known 
to synthesise at least part of their pyrimidine re- 
quirements de novo from aspartate, glutamine and 
carbon dioxide [5-81 and are therefore presumably 
relatively insensitive to inhibitors of pyrimidine 
salvage pathways. We recently reported on the 
ability of the protozoan Trichomonas vaginalis, 
the causative agent of trichomonal vaginitis, to sal- 
vage the purines adenine and guanine and their. 
nucleosides, and on the apparent inability of the 
organism to interconvert adenine and guanine 
nucleotides and to synthesise the purine ring de 
novo [9]. We describe here similar experiments, 
using both preformed pyrimidines and precursors 
of the pyrimidine ring, which indicate that the 
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organism is able to salvage bases and nucleosides 
and to interconvert uracil and cytosine compounds, 
but, in contrast to the majority of the parasitic 
protozoa, is unable to synthesise the pyrimidine 
ring. In addition, enzymic studies failed to demon- 
strate thymidylate synthase cycle activities in T. 
vaginalis, suggesting that this protozoan is depen- 
dent upon an exogenous source of thymidine for 
TMP synthesis. 
2. MATERIALS AND METHODS 
2.1. Growth and harvesting of organisms 
Trichomonas vaginalis (Bushby strain) from the 
Wellcome Research Laboratories was grown, har- 
vested and washed as described in [9]. 
2.2. Pyrimidine incorporation experiments 
Cells were incubated aseptically at 37°C at an 
initial density of lo6 cells/ml in 10 ml of a defined 
medium, based on that described in [S]. The 
medium contained either preformed, radiolabelled 
pyrimidines at a final concentration of 80pM and 
5&i/ml, or potential precursors of the pyrimidine 
ring. The precursors used were Na[r4C]bicarbo- 
nate (180pM, S&i/ml), [6-14C]orotate (80/tM, 
Published by Elsevier Science Publkhets B. K 
00145793/84/$3.00  1984 Federation of European Biochemical Societies 55 
Volume 176, number 1 FEBS LETTERS October 1984 
1 &i/ml) and [U-r4C]aspartate (EEOpM, 5pCVml). 
As T. vaginalis is neither able to synthesise purines 
nor to interconvert adenine and guanine nucleo- 
tides [9], adenine and guanine were included in all 
incubations at 80pM. Samples (1 ml) were re- 
moved at intervals, rapidly mixed with cold 5% 
(w/v) trichloroa~~ic acid, collected on Millipore 
filters (1.2pm pore size) and treated as in f9f. The 
ra~oa~tivity in the arid-insoluble material (pro- 
tein, nucleic acid and glycogen) was measured in a 
toluene-based liquid scintillation fluid. 
2.3. Chemical fractionation of cellular material 
After incubation for 4 h the remaining organ- 
isms were washed twice with phosphate-buffered 
saline. The resulting pellet of cells was extracted 
twice with 5% (w/v) trichloroacetic acid at 4°C for 
30 min, twice with an ethanol/ether mixture (50: 50 
by volume) at 45 “C for 15 min to remove lipids and 
finally twice with 5% (w/v) t~c~oroaceti~ acid at 
95°C for 30min to give a fraction containing 
solubilised nucleic acids. Details of the subsequent 
hydrolysis of the nucleic acids, chromatography of 
the resulting bases and the determination of radio- 
activity profiles are given in [9]. 
In some experiments with the deoxyribonucleo- 
sides thymidine and deoxycytidine, DNA and 
RNA were extracted separately after the etha- 
nol/ether treatment, using the method of [lo] as 
modified in [ll]. 
2.4. Enqvme assays 
Cell-free extracts of T. vag~~a~is, prepared as 
described in (91, were used in the following enzyme 
assays, all of which are based on previously pub- 
lished methods. 
Thymidylate synthase was measured by following 
the release of 3H~0 from [5-“HIdUMP [12]. Cen- 
trifugation was used rather than filtration, to re- 
move the Norit A charcoal added to stop the reac- 
tion, as this resulted in lower and more stable levels 
of background radioactivity. The assay mixture 
for thymidine kinase, based on [13], contained 
50 mM Hepes (pH 7.5) 5 mM ATP, 5 mM MgC]s, 
15 mM NaF, 0.2 mM [2-i4C]thymidine (specific 
activity 2.5 mCi/mmoI) and cell extract in a total 
volume of 1OOpl. Reactions were stopped by heating 
at 95°C for 4 min, and 20$ portions spotted on to 
DEAF discs (Whatman DE81). To remove un- 
reacted thymidine, these were rapidly washed 5 
56 
times in 1 mM ammonium formate (- 10 ml/disc) 
and once in methanol, and the remaining radio- 
activity measured by scintillation counting after 
the addition of 5 ml PCS (Amersham). Dihydro- 
folate reductase and serine hydroxymethyltransfer- 
ase were assayed using the methods in [14] and 
[ 1 !I], respectively. 
Carbamoyl-phosphase synthase was assayed by 
following the formation of [‘“Cl citrulline from 
[ 14C] bicarbonate in the presence of excess ornithine 
and ornithine carbamoyltransferase, as described 
in [16]. Aspartate carbamoyltransferase and di- 
hydroorotase were measured as in [ 171 and [ 181, 
respectively. Dihydroorotate dehydrogenase was 
assayed spectrophotometricahy as described in [ 191. 
The final two enzymes in the pyrimidine biosynthe- 
tic pathway, orotate phosphoribosyltr~sfer~e and 
orotidine 5-phosphate decarboxylase, were assayed 
simultaneously using [6-t4C] orotate (5 mCi/mmol) 
(and in the presence of excess commercial orotate 
phosphoribosyltransferase in the case of the decar- 
boxylase), and the substrate and products separ- 
ated by thin-layer chromatography on PEI-cellu- 
lose with 0.2 M LiCl [ZO]. 
Protein was measured by the method of [Zl] 
using bovine serum albumin as a standard. 
3. RESULTS 
Comp~ative figures for the incor~ration of 
py~~~nes into the cold trichloroa~etic acid- 
insoluble fraction of T. vaginalis are shown in 
table 1. In~or~ration remained linear with time 
Table 1 
Incorporation of pyrimidines into the nucleic acid of 
T. vaginalis 
Pyrimidine 
f6-3H] Uracil 
[6-3HJThymine 
[5-3H]Cytidine 
Deoxy 15-3H] cytidine 
[G-3H]Uridine 
[6-3H]Thymidine 
[5-“H]UMP 
[5-3H]UMP 
@mol. 106 cells-‘+4 h-l)a 
1,026 f 0.086 (5) 
0.011 I 0.001 (3) 
1.629 AZ 0.164 (5) 
1.126 f 0.153 (3) 
1.741 f 0.378 (5) 
0.039 If: 0.007 (4) 
0.246 (2) 
0.32Jb (2) 
aMean j: SD (no. determinations) 
b Obtained in the presence of 10 mM NaF 
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for more than 6 h. The value for uracil compares 
well with those given for adenine and guanine (1.09 
and 1.05 nmol * IO6 cells-’ + 4 h- * , respectively) in 
[9]. There appears to be some preference for the 
pyrimidine nucleosides compared to the base. The 
higher values for incorporation of pyrimidine 
nucleosides compared with purine bases and 
nucleosides were the first indication obtained that, 
unlike purines, they are interconvertible. The rate 
of UMP incorporation was not decreased in the 
presence of NaF, added to inhibit extracellular 
phosphatase activity, suggesting that this nucleo- 
tide is taken up intact, albeit slowly. 
As found for other parasitic protozoa [l] there 
was negligible uptake of thymine; thymidine 
salvage was also low, but the ratio of thymidine in- 
corporation to that of adenine (none of which is 
converted to guanine [9]) is approximately 1: 28, 
which corresponds closely to the ratio of DNA to 
RNA in the trichomonal cell (1: 27, unpublished). 
Deoxycytidine was salvaged to a much greater ex- 
tent than thymidine, suggesting that this deoxy- 
riboside is incorporated into both RNA and DNA. 
This was substantiated by chemical separation of 
the nucleic acids which revealed that deoxycytidine 
labelled DNA and RNA in the ratio 1: 25, after 
allowing for -5% alkaline digestion of the DNA 
seen in control experiments using thymidine. 
Evidence for active interconversion between 
cytosine and uracil nucleosides/nucleotides is 
shown in fig. 1. The nucleic acid of cells incubated 
with either [‘HI cytidine or [‘HI uridine contained 
both labelled uracil and cytosine bases. Incubation 
with labelled thymidine resulted solely in the label- 
ling of the thymine base. 
Fig.1 also shows the total absence of incor- 
poration of 14C from [r4C]bicarbonate into the 
pyrimidine bases of trichomonal nucleic acid; simi- 
larly there was no trace of incorporation from 
[U-r4C]aspartate and [6-14C]orotate. Aspartate 
and a small amount of bicarbonate were incor- 
porated into the protein of the cell, indicating the 
continuation of macromolecular synthesis during 
incubation. 
Attempts to detect thymidylate synthase in cell- 
free extracts of T. vaginalis proved negative. Ex- 
tracts of Trypanosoma cruzi were assayed under 
identical conditions as a positive control. A speci- 
fic activity of 2.40 + 0.52nmol*min-‘-mg pro- 
tein-’ was obtained for the trypanosomal enzyme 
1 
0 I[ 
I I 1 I I J 
0 0.2 0.4 0.6 0.8 1.0 
R f 
Fig. 1. Radioactivity profiles of chromatographed nucleic 
acid (DNA + RNA) hydrolysates after incubation of 
T. vaginalis with radiolabelled cytidine (o), uridine (0), 
thymidine (m) and bicarbonate (A). Markers: G, guanine; 
A, adenine; C, cytosine; U, uracil; T, thymine. 
and this value was unaffected by the addition of T. 
vaginalis extracts. An attempt was also made to 
detect activity of dihydrofolate reductase and 
serine hydroxymethyltransferase, both of which 
are intimately connected in a cycle with thymidy- 
late synthase in many organisms, especially in 
trypanosomes, where the former occurs with thy- 
midylate synthase as a bifunctional protein [22]. 
Using the standard, relatively sensitive, assay 
methods, neither enzyme was detected in T. 
vaginalis. In this context it is interesting to note 
that when suspensions of T. vaginalis were incu- 
bated with radiolabelled formate or methyl-labelled 
[ 14C]serine, either of which could theoretically 
supply the 5-methyl carbon of TMP, neither la- 
belled the thymine residues of trichomonal DNA 
[9]. The limits of our detection of thymidylate syn- 
thase were 0.002 nmol*min-’ *mg protein-‘; this 
would not be high enough to support the organ- 
ism’s requirement for thymidine (60.008 nmol. 
57 
Volume 176, number 1 FEBS LETTERS October 1984 
min-‘*mg protein-‘), calculated on the basis of 
known DNA content and doubling time (28 /rg * lo8 
cells-’ and 6.5 h, respectively; unpublished). 
The absence in T. vaginalis of TMP synthesis 
from dUMP implies a dependence on the uptake of 
preformed thymidine. Metabolism to the nucleo- 
side monophosphate is presumably achieved by 
thymidine kinase, which was detected in cell-free 
extracts at a specific activity of 2.10 f 0.60 
(n G 3) nmol~min-l~mg protein-‘. 
Preliminary reports 1231 that, in spite of the 
apparent absence of de novo pyrimidine synthesis 
from radiolabelled precursors in T. vaginalis, 
activity of all 6 pyrimidine biosynthetic enzymes 
could be detected have not been confirmed. A 
stable, ammonia-dependent carbamoyl-phosphate 
synthase (CPS) was ‘found with a specific activity 
of 2.14 f 0.53 (n = 4)nmol~min-’ *mg protein-’ 
but its inactivity with glutamine and lack of inhibi- 
tion by pyrimidine nucleotides suggests that it is 
similar to the’ arginine-specific mammalian CPS I 
rather than the pyrimidine-specific CPS II [24]. 
Aspartate carbamoyltransferase activity at a speci- 
fic activity of 5.70 f 1.31 (n = 4)nmol~min-‘emg 
protein-’ was also detected in 1’. vaginal& as were 
low levels of dihydroorotase and dihydroorotate 
dehydrogenase (co.2 nmol~min-' *mg protein-‘), 
but further attempts to detect he last two enzymes 
of the pathway, orotate .phosphoribosyltransferase 
and orotidylate decarboxylase, proved negative. 
Thus, overall, our experiments on whole cell utili- 
sation of pyrimidine precursors and further enzy- 
matic studies both point to the same conclusion: 
there is no pyrimidine biosynthesis de novo in T. 
vaginalis. 
4. DISCUSSICN 
The non-incorporation of bicarbonate, orotate 
and aspartam into the pyrimidine ring and the 
apparent absence of the final two enzymes of the 
de nave synthetic pathway -is evidence that T. 
vaginalis (Bushby strain) is unable,to synthesise the 
pyrimidine ring, but must rely upon the salvage of 
exogenous, preformed pyrimidines. This is an un- 
usual situation in the parasitic protozoa which are 
generally considered to derive at least some of their 
pyrimidine requirement from biosynthesis [5-81. 
However, recent reports have shown that Giardia 
lamblia [25] and Tritrichomonas foe&s [26,27] 
58 
also lack the de novo pathway, and T. foetus was 
shown to incorporate uracil, uridine, &dine and 
thymidine into pyrimidine nucleotides [26,27]. T. 
vaginalis (ATCC 30001) has also recently been 
shown to lack de novo pyrimidine biosynthesis, 
and to salvage pyrimidine bases and nucleosides 
[281. 
The presence in T. vaginalis of several pyrimi- 
dine salvage enzymes, including nucleoside phos- 
phorylages and kinases, has been demonstrated 
[29], and the results presented here confirm that 
these pathways are actively involved in the essen- 
tial salvage of a range of pyrimidine bases and 
nucleosides. Current knowledge of pyrhnidine 
salvage pathways in T. vaginalis is summarised in 
fig.2. 
Cytosine was not used in this study, but the 
absence of cytidine synthesis from cytosine by a 
phosphorylase in T. vaginalis [29], and the absence 
of cytosine phosphoribosyltransferase from T. 
foetus [26], suggest that Trichomonas cannot 
TTP UTP - CTP dCTP 
I9 I9 ‘O I9 I%? 
TDP UDP COP dCDP 
I7 I7 I7 I7 
TMPI---dUMP UMP CMP dCMP 
I” 
: 
I6 I6 I6 
Tdr 
I3 ’ “17 c[;,,,,,//wr ‘“1 
2 
Fig.2. Pathway8 of pyrimidine in T. vaginalis: (-) 
pathways hown by euzyrnic or metabolic studies to be 
present; (L--+) pathways apparently absent. Enzymes 
are: 1, ur&il phosphoriho8yltransferase; 2, (deoxy)uri- 
dine phosphoryIase; 3, thymidine phosphoryIase; 4, 
(deoxy)cytidine phosphorylase; 5, (deoxy)cytidine de- 
aminase; 6, py-rimiclmb nucleoside kinase; 7, nucleoside 
monophosphate kinase; 8, thymidylate synthase; 9, 
nucleoside diphosphate kiie; 10, CTP synthetase. U, 
uracil; C, cytosine; Ur, uridine; Udr, deoxyuridine; 
Cr, @dine; Cdr, deoxycytidine; T, thyrnine; Tdr, 
thymidine. 
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utilise this base. Prior to the incorporation of the 
labelled cytosine ring of deoxy[5-3H]cytidine into 
RNA it must be converted from a deoxyribose to 
a ribose derivative. Of the two possible routes for 
this conversion, via deoxyuridine and uracil (in- 
volving cytidine deaminase and phosphorylase n- 
zymes) and via cytosine (involving a nucleoside 
phosphorylase), the first seems the most likely in 
view of the absence or very low activity of cytidine 
phosphorylase in T. vaginalis and the presence of 
(deoxy)cytidine deaminase and (deoxy)uridine 
phosphorylase [29]. These two enzymes were also 
detected in T. foetus [26]. 
Deamination at the nucleoside level is the nor- 
mal pathway of conversion from cytosine to uracil 
based compounds, whilst conversion in the oppo- 
site direction principally occurs by amination at 
the triphosphate level. T. vaginalis freely inter- 
converts cytidine and uridine (fig. l), and possesses 
cytidine deaminase [29] for the cytidine to uridine 
conversion; it seems reasonable to assume that 
CTP synthetase, converting UTP to CTP, is pres- 
ent in the Bushby strain of T. vaginalis used in this 
study. In contrast to these results, no incorpora- 
tion of uracil or uridine into cytosine nucleotides 
was seen in T. vagindis (ATCC 30001), although 
cytidine incorporation into uracil nucleotides was 
detected [28]. There appear to be distinct en- 
zymatic differences between this strain of the 
organism and the Bushby strain, in that pyrimidine 
nucleoside phosphotransferases predominate in 
the former, whereas uridine kinase and thymidine 
kinase are present in the latter [28,29]. 
The absence of thymidine synthase and dihydro- 
folate reductase from T. vaginalis is in striking 
contrast to all other parasitic protozoa studied, 
with the exception of T. foetus [26], and the 
majority of all other cells. Thymidine salvage in T. 
vaginalis appears to depend upon thymidine 
kinase, which has previously been detected in the 
organism [29], although at a lower specific activity 
(0.37 nmol*min-‘* mg protein-‘) than the value re- 
ported here. In T. foetus, thymidine is phosphory- 
lated not by a kinase but by a phosphotransferase, 
for which a range of nucleoside monophosphates 
were effective phosphate donors [26]. There is one 
report that a similar enzyme occurs in T. vaginalis 
WI. 
The results presented here, together with those 
in [28] and [29], show that the pyrimidine meta- 
holism of T. vaginalis is dissimilar to that in most 
other genera of parasitic protozoa and the majority 
of mammalian tissues. These metabolic studies 
substantiate the suggestion made after experiments 
with a defined growth medium, that both purines 
and pyrimidines are obligate growth factors for T. 
vaginalis [30], and highlight the apparent sim- 
plicity of the pyrimidine salvage network, with thy- 
midine metabolism quite independent of the other 
pathways. From a chemotherapeutic point of view, 
the inability of T. vaginah to synthesise the pyri- 
midine ring and its consequent dependence on the 
salvage of preformed pyrimidines, is as potentially 
interesting as the organism’s dependence upon pre- 
formed purines. 
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